Table 1. Genetic and clinical features of the human tumors samples.

Patients	Histological data	Genetic analyses			Relevant clinical data
		BRAF	TP53	TERT
4	Papillary, pT3N1b	WT	WT	nd	WDTC, persistent disease, lung metasstasis
5	Papillary, pT1Nx	p.V600E	WT	nd	WDTC, cured
6	Papillary, pT3N0	p.V600E	WT	WT	WDTC, cured
7	PDTC, pT4aN1	WT	WT	nd	External radiotherapy, surgery for endotracheal recurrence, persistent disease
8	PDTC, pT3N1	p.V600E	WT	p.C228T	Biochemical persistence
9	PDTC, pT3N1b	WT	c.920-2A>G	WT	Resistant to tyrosine-kinase inhibitor, disease-related death at 26 years
10	PDTC, pT4aN1b	p.V600E	WT	WT	Persistent disease, local recurrence
11	PDTC, pT4aNx	WT	WT	WT	Persistent disease, lost at follow-up
12	PDTC, pT4aN1b	WT	WT	nd	Local recurrence, disease-related death at 77 years

The table summarize the histological, genetic and clinical data of patients with thyroid malignancies.

WDTC, well differentiated thyroid cancer; PDTC, poorly differentiated thyroid cancer; nd, not done.